View in EDS HTML Full Text PDF Full Text

Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients.

Saved in:
Bibliographic Details
Title: Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients.
Authors: Lin, Ming-Hsun1 (AUTHOR), Ye, Ren-Hua2 (AUTHOR), Jhou, Hong-Jie3 (AUTHOR), Chen, Hsin-Yu4 (AUTHOR), Kao, Li-Ting5,6,7 (AUTHOR), Hsieh, Tina Yi-Jin8 (AUTHOR), Chen, Yu-Han9 (AUTHOR), Yue-En Sun, Andrea10 (AUTHOR), Zhang, Xiaoyi11 (AUTHOR), Dai, Ming-Shen2 (AUTHOR), Ho, Ching-Liang2,12 (AUTHOR), Chen, Po-Huang2 (AUTHOR) chenpohuang@hotmail.com, Lee, Cho-Hao2 (AUTHOR) drleechohao@gmail.com
Source: Diabetology & Metabolic Syndrome. 10/3/2025, Vol. 17 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17585996
DOI:10.1186/s13098-025-01940-0